these results suggest that , at least in part , the potentiation of epinephrine-induced hyperglycemia by dihydropyridines , non-dihydropyridines and hydralazine is related to the inhibition of peripheral glucose utilization produced by insulin .
C0020456
hyperglycemia
C0017725
glucose